H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) shares dropped 0% during mid-day trading on Monday . The company traded as low as $22.00 and last traded at $22.00. Approximately 7,500 shares traded hands during mid-day trading, an increase of 327% from the average daily volume of 1,758 shares. The stock had previously closed at $22.01.
H. Lundbeck A/S Price Performance
The firm has a market cap of $21.91 billion, a PE ratio of 25.00 and a beta of 0.68. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.15 and a quick ratio of 0.71. The firm has a 50-day simple moving average of $22.00 and a 200 day simple moving average of $22.00.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Featured Articles
- Five stocks we like better than H. Lundbeck A/S
- What is MarketRank™? How to Use it
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- What is the Dogs of the Dow Strategy? Overview and Examples
- Applied Materials Market Capitulates: Now is the Time to Buy
- What is the FTSE 100 index?
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
